Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico

Cancer Causes and Control

Volumn 14, Issue 6, 2003, Pages 505-512

  Salmerón, Jorge ^a   Lazcano Ponce, Eduardo ^b   Lorincz, Attila ^c   Hernández, Mauricio ^b   Hernández, Pilar ^b   Leyva, Ahideé ^b   Uribe, Mario ^a   Manzanares, Horacio ^a   Antunez, Alfredo ^a   Carmona, Enrique ^a   Ronnett, Brigitte M ^d   Sherman, Mark E ^d   Bishai, David ^e   Ferris, Daron ^f   Flores, Yvonne ^a   Yunes, Elsa ^b   Shah, Keerti V ^e  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c Digene Corporation   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cervical cancer; HPV assays; Mexico; Pap smears

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEXICO; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTODIAGNOSIS; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; MEXICO; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0042734420     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024806707399     Document Type: Article

References (31)

1. Lara E, Day NE, Hakama M (1987) Trends in mortality from cervical cancer in the Nordic countries: Association with organized screening programs. Lancet 1: 1247.
2. Mitchell MF, Tortolero-Luna G, Wright TC, et al. (1996) Cervical human papillomavirus infection and intraepithelial neoplasia: a review. Monogr Natl Cancer Inst 21: 17-25.
3. World Health Organization (1995) The World Health Report 1995. Bridging the Gaps. Geneva, Switzerland: WHO.
4. Ponten J, Adami HO, Bergstrom R, et al. (1995) Strategies for global control of cervical cancer. Int J Cancer 60(1): 1-26.
5. Robles S, White F, Peruga A (1996) Trends in cervical cancer mortality in the Americas. Bull Pan Am Health Org 30: 290.
6. Beral V, Hermon C, Muñoz N, Devesa S (1994) Cervical cancer. Trends in cancer incidence and mortality. Cancer surveys. Imperial Cancer Res Fund 19/20: 265.
7. Lazcano EC, Moss S, Alonso P, Salmerón J, Hernández M (1999) Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico. Arch Med Res 30: 240-250.
8. Hernández M, Lazcano EC, Alonso P, Romieu I (1998) Evaluation of the cervical screening program in Mexico: a population based case control study. Int J Epidemiol 27: 370-378.
9. Fahey MT, Irwig L, Mascaskill P (1995) Meta-analysis of Pap test accuracy. Am J Epidemiol 141(7): 680-689.
10. Sasieni PD, Cuzick J, Lynch-Farmery E (1996) NCN Working Group. Estimating the efficacy of screening by auditing smears histories of women with and without cervical cancer. Br J Cancer 73: 1001-1005.
11. Bonn D, Bradbury J (1998) The warts and all approach to tackling cervical cancer. Lancet 351: 810.
12. Cuzick J, Meijer CJ, Walboomers JM (1998) Screening for cervical cancer. Lancet 351: 1439-1440.
13. Scheck A. (1996) Will the HPV DNA test upstage the Pap smear? IVD Technol Mag 8.
14. Sasieni PD (2000) Human papillomavirus screening and cervical cancer prevention. JAMA 55(4): 216-219.
15. Cuzick J, Sasieni PD, Davies P, et al. (1999) A systematic review of the role of human papillomavirus testing within a cervical screening programme, Health Technol Assess 3(14): 1-204.
16. Ratnam S, Franco EL, Ferenczy A (2000) Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol, Biomarkers Prev 9: 945-951.
17. Schiffman M, Herrero R, Hildesheim A, et al. (2000) HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 283(1): 87-93.
18. Cuzick J, Beverly E, Ho L, et al. (1999) HPV testing in primary screening of older women. Br J Cancer 81(3): 554-558.
19. Clavel C, Masure M, Bory JP, et al. (1999) Hybrid Capture II-base human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a primary study on 1518 women. Br J Cancer 80(9): 1306-1311.
20. Wright TC, Denny L, Kuhn L, Polleck A, Lorincz A (2000) HPV-DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 283: 81-86.
21. Flores Y, Shah KV, Lazcano EC, et al. (2002) Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: the Morelos HPV Study. Salud Pública de México 44(4): 335-344.
22. Manual of the Histologic Staining Methods of the Armed Forces (1968) Institute of Pathology, 3rd edn, p. 68.
23. Luff RD (1992) The Bethesda System for reporting cervical/vagina cytologic diagnoses: report of the 1991 Bethesda workshop. Hum Pathol 23: 719-721.
24. Lorincz A (1996) Hybrid Capture™ method for detection of human papillomavirus DNA in clinical specimens. Papillomavirus Report 7: 1-5.
25. Reid R (1990) Colposcopy of cervical preinvasive neoplasia. In: Singer A, ed. Premalignant Lesions of the Lower Genital Tract. Vol. 2. New York: Elsevier, 87-116.
26. Meijier CJ, Rozendaal L, van der Linden JC, et al. (1997) Human papillomavirus testing for primary cervical cancer screening. In: Franco E, Monsonegro J, eds. New Developments in Cervical Screening and Prevention. Oxford Blackwell Science, 338-357.
27. Cuzick J, Sasieni P (1997) Estimates of the cost impact to introducing HPV testing into a cervical screening programme. In: Franco E, Monsonegro J, eds. New Developments in Cervical Screening and Prevention. Oxford Blackwell Science, 364-372.
28. Lazcano-Ponce E, Alonso P, López L (1997) Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centers in México. Acta Cytológica 41(29): 277-284.
29. Sellers JW, Lorincz AT, Mohany JB, et al. (2000) Comparison of self-collected vaginal, vulvar and urine samples with physicians-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 163(5): 513-518.
30. Kenney W, Sung HY, Kearney KA, Miller A, Sawaya G, Hiatt PA (1998) Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer. Gynecol Oncol 71: 428-430.
31. Dzuba IG, Allen B, Flores Y, et al. (2002) The acceptability of self-collected samples for HPV testing vs. the Pap test as alternatives in cervical cancer screening. J Womeńs Health Gender-Based Med 11(3): 265-275.